Genelux Corporation (GNLX) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 2 Buy, 1 Hold.
The consensus price target is $17.33 (low: $16.00, high: $20.00), representing an upside of 510.2% from the current price $2.84.
Analysts estimate Earnings Per Share (EPS) of $-0.88 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.95 vs est $-0.88 (missed -8.2%). 2025: actual $-0.86 vs est $-0.85 (missed -1.6%). Analyst accuracy: 95%.
GNLX Stock — 12-Month Price Forecast
$17.33
▲ +510.21% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Genelux Corporation, the average price target is $17.33, with a high forecast of $20.00, and a low forecast of $16.00.
The average price target represents a +510.21% change from the last price of $2.84.
Highest Price Target
$20.00
Average Price Target
$17.33
Lowest Price Target
$16.00
GNLX Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to Genelux Corporation in the past 3 months
EPS Estimates — GNLX
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.95
vs Est –$0.88
▼ 7.6% off
2025
Actual –$0.86
vs Est –$0.85
▼ 1.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — GNLX
80%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▲ 40.0% off
2025
Actual $0.000B
vs Est $0.000B
▼ 0.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
